Undiagnosed endometrial abnormalities in women with normal hysterosalpingography scheduled for IVF: prospective evaluation of three-dimensional transvaginal ultrasound versus office hysteroscopy by Abdelmagied, Ahmed M et al.
Proceedings in Obstetrics and Gynecology, 2020;10(1):5 
Please cite this paper as: Abdelmagied AM, Kamel MA, Abuelhasan A, Nassr A, Shazly S, Habib DM, Badran E, Ali 
MK, Abbas AM. Undiagnosed endometrial abnormalities in women with normal hysterosalpingography scheduled for 
IVF: prospective evaluation of three-dimensional transvaginal ultrasound versus office hysteroscopy. Proc Obstet 
Gynecol. 2020;10(1):Article 5 [ 18 p.]. Available from: http://ir.uiowa.edu/. Free full text article. 
Corresponding author: Ahmed M. Abbas, MD, Department of Obstetrics and Gynecology, Assiut University, Egypt,  
Women Health Hospital, 71511, Assiut Egypt. Cellular: +20 10033851833. Tel: +20 88 2414616. Fax: +20 88 
9202503. E-mail:bmr90@hotmail.com 
Financial Disclosure: The authors report no conflict of interest. 
Copyright: © 2020 Abdelmagied et al. This is an open-access article distributed under the terms of the Creative 
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided 
the original author and source are credited. 
1 
 
Undiagnosed endometrial abnormalities in women with normal 
hysterosalpingography scheduled for IVF: prospective evaluation of 
three-dimensional transvaginal ultrasound versus office 
hysteroscopy 
Ahmed M. Abdelmagied,1 Momen A. Kamel,1 Ahmed Abuelhasan,1 Ahmed Nassr,1 
Sherif Shazly,1 Dina M. Habib,1 Esraa Badran,1 Mohammed K. Ali,1 Ahmed M. Abbas1 
Keywords: Three-dimensional ultrasound, multi-slice view, office hysteroscopy, in vitro fertilization, cost 
modeling 
Abstract 
Objectives: To compare the diagnostic 
accuracy of three-dimensional transvaginal 
ultrasound (3D-US) to office hysteroscopy (OH) 
in the screening of uterine cavity with normal 
hysterosalpingography (HSG) findings for subtle 
endometrial abnormalities before in vitro-
fertilization (IVF).  
Methods: A prospective cohort cost-modeling 
study was carried out in a University hospital. 
We included 120 infertile women with a normal 
uterine cavity on HSG scheduled for IVF. All 
cases were evaluated by 3D-US, and the results 
were compared with OH findings. 
Results: OH revealed cavitary endometrial 
lesions (CLs) in thirty-four women (28.3%). 
Endometrial polyps were the most common 
detected lesions (16, 47.1%). 3D-US had 88.2% 
sensitivity, 96.5% specificity, 90.9% positive 
predictive value, 95.4% negative predictive 
value, and 94.2% overall accuracy for CLs. The 
overall agreement between 3D-US and OH was 
near-perfect (κ=0.86, 95% CI=0.75-0.96). 
Irregular menstrual bleeds and prior endometrial 
procedures were significant predictors for CLs 
(aOR=24.96, 95% CI=2.71–230.04, P=0.005, 
aOR=9.16, 95% CI=2.13–39.3, P=0.002, 
respectively). A selective screening strategy 
discerning OH to women with these predictors 
and/or women with abnormal 2D-US would have 
an NPV of 92.8 % with substantial cost benefits.  
Conclusions: In the pre-IVF work up, 3D-US, a 
non-invasive imaging modality, seems to be 
nearly comparable to OH. Office hysteroscopy 
screening prioritizing women with abnormal 2D-
US, irregular menstrual periods and/or prior 
endometrial traumatization could yield a 
satisfactory cost-effective approach for 
identifying endometrial lesions.   
1Department of Obstetrics and Gynecology, 
Faculty of Medicine, Assiut University, Egypt. 
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Introduction 
Evaluation of the endometrial cavity is 
an important step in the infertility 
workup, particularly if assisted 
reproductive therapy is planned. The 
aim is to identify possible endometrial 
abnormalities that may impair 
implantation.1,2 Hidden endometrial 
abnormalities are present in 11 to 45% 
of women scheduled for in vitro 
fertilization (IVF).3-6 Traditionally, two-
dimensional transvaginal ultrasound 
(2D-US) and hysterosalpingography 
(HSG) are the primary methods for 
assessment of the endometrial cavity. 
However, these imaging modalities have 
shown high false-negative rates among 
infertile women, a finding that could 
confine their use to initial screening 
rather than definite diagnosis.2,6-10  
Office hysteroscopy (OH) is the 
reference standard for the evaluation of 
the endometrial cavity. Evidence on the 
treatment of unsuspected 
hysteroscopically-diagnosed 
endometrial lesions, to improve IVF 
outcome, is still lacking.11,12 A recent 
randomized controlled trial (RCT) that 
compared IVF outcomes among small 
numbers of treated as well as untreated 
lesions demonstrated similar clinical 
pregnancy and live birth rates.13 In low 
income and resource countries, where 
governmental insurance provides the 
main coverage for IVF cycles, the 
psychological and financial 
consequences of failed IVF cycles are 
unjustifiable.14  
Recently, there has been emerging 
evidence that the use of saline infusion 
in combination with 3D ultrasound 
imaging could present an alternative to 
OH.8,11,15,16 With the advance of 3D 
software, the coronal view of the uterus 
can be exhibited in many displays: multi-
planar view (MPV), surface rendering, 
and power Doppler modes. All have 
been studied before for the detection of 
the intrauterine lesions with satisfactory 
results.15-17 
Our objective was to propose imaging-
based strategies that may replace or 
minimize the use of OH before IVF for 
the detection of hidden intrauterine 
abnormalities. To achieve this purpose, 
we evaluated 3D-US using both multi-
planar view (MPV) and multi-slice view 
(MSV) of the uterine cavity in 
comparison to OH, the gold standard, 
for diagnosis of cavitary endometrial 
lesions (CLs) in women scheduled for 
IVF. Also, we assessed an OH 
screening strategy, selectively 
comprised women with abnormal 2D 
TVUS and/or clinical predictors for CLs, 
in terms of diagnostic accuracy and 
cost. 
Materials and Methods 
This was a prospective cohort study. 
The study's protocol was approved by 
The Research Ethics Committee of 
Faculty of Medicine, Assiut University. 
Women attending the infertility 
outpatient clinic and IVF center of a 
single university-affiliated hospital 
between July 2014 and October 2015 
were considered for enrollment. Women 
were considered eligible if they were 
selected for IVF therapy, had a history 
of primary infertility, and had a normal 
uterine cavity on initial HSG done within 
one year before the enrollment.  
Women with a known diagnosis of 
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uterine abnormality by prior OH after 
normal HSG were excluded from the 
study. After appropriate counseling, 
women were offered to participate in the 
study after written informed consent. 
Sonographic Examination 
Following the initial clinical assessment, 
all women were scheduled to have a 
sonographic examination within 48 
hours of cessation of menstrual flow. 
Sonographic examinations were 
performed by the same sonographer 
using a Medison SonoAce X8 (Medison 
Co., Seoul, Korea) with a 3D/4D 
volumetric 12mm endocavitary, trans-
vaginal, probe (3D4-9ES [4-9 MHz]).  
Endometrial cavities were first evaluated 
using a 2D ultrasonographic view on two 
planes: sagittal and transverse. After 
that, 3D volumes were acquired from 
the mid-sagittal plane of the uterus while 
the entire uterus was included in the 
volume box. Both cervical and 
endometrial canals were completely 
visualized in continuity, and the probe 
was kept steady by the examiner. To 
generate the volume, 3D Static Mode 
was used with a maximum sweep angle 
of 120 degrees, and the subject was 
asked to hold her breath and to remain 
still. 3D volumes were obtained and 
stored digitally. The volumes were 
analyzed offline using MPV and MSV of 
the mid-coronal plane of the uterus. For 
the multi-planar display of the mid-
coronal plane, Z technique was utilized 
as described by Abuhamad et al.18 MSV 
then evaluated all coronal views. For 
each coronal view, parallel slices of 0.5 
mm depth difference were studied 
simultaneously on the same screen.  
The 3D scans were examined for 
endometrial abnormalities such as 
polyps, sub-mucosal myomas (SMM), 
intrauterine adhesions (IUA), and 
congenital anomalies. An endometrial 
polyp was identified as focal 
hyperechoic thickening of the 
endometrium, with a preserved 
myometrial-endometrial junction. A sub-
mucous myoma (SMM) was defined as 
a mixed or hypoechoic lesion originating 
from the myometrium and interrupting 
myometrial-endometrial junction. 
Adhesions were defined as bands that 
separated the endometrial cavity and 
caused distorted or irregular endometrial 
line. For the diagnosis of a congenital 
uterine anomaly, outer and inner fundal 
contours and the length of the fundal 
indentation were analyzed. The 
American Society for Reproductive 
Medicine description of the anomalies 
was followed to categorize the 
findings.19 For imaging analysis of the 
uterine morphology, standards in the 
literature were utilized to define each 
anomaly20,21 appropriately. 
Office Hysteroscopy Examination 
Office Hysteroscopy was conducted on 
the same day of sonographic 
examination. Hysteroscopic 
examinations were done in the office 1-4 
months before the IVF cycle by the 
same investigator (reproductive 
endocrinologist with more than ten 
years' experience in hysteroscopy) who 
was blinded to 3D-US results. Women 
were pre-medicated by vaginal 
misoprostol 200ug for cervical ripening 
12 hours before the procedure. The 
procedure was performed utilizing a 3.5-
mm outer diameter, single, continuous 
flow rigid hysteroscope with a 30-degree 
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forward-oblique lens (2.7-mm in 
diameter) (Wolf Lumina®, Richard Wolf 
GmbH, Germany). Vaginoscopic 
approach ("no-touch" technique) was 
utilized without anesthesia or any 
cervical manipulations. Sterile normal 
saline solution 0.9% was used to 
distend the vagina and the uterus with 
the pressure kept between 50 and 100 
mmHg. 
During OH, the observations were 
explained to the subjects on set through 
a video screen. Participants were 
blinded to the sonographic results and 
were observed for 1-hour post-
procedure. 
Inter/Intra-observer Agreement 
To calculate the inter-observer 
agreement for 3D-US diagnosis, two 
study investigators independently 
studied the digitally stored 3D volumes. 
They conducted another evaluation four 
weeks later for the calculation of the 
intra-observer agreement. The study 
investigators who evaluated 3D volumes 
were reproductive endocrinologists with 
five years' experience in 3D imaging. 
Statistical Analysis 
Statistical analysis was performed using 
STATA version 13 (STATA corp., 
College Station, TX, USA). Shapiro-Wilk 
test was used as a test of normality for 
continuous variables. Parametric 
variables were expressed as mean± 
standard deviation (SD), while skewed 
variables were described using the 
median and the inter-quartile range 
(IQR). Mann Whitney U test was used to 
compare the median of non-parametric 
variables. Chi-square and Exact Fisher's 
tests were used to compare proportions 
as appropriate. 
Univariate logistic regression was 
conducted to identify potential clinical 
predictors of CLs. Independent variables 
that had P values < 0.2 were considered 
in multivariate logistic regression. 
Uncentered variance inflation factor 
(VIF) was used to assess collinearity; 
variables that had VIF > 10 were 
deemed to be collinear. Continuous 
variables were divided using cutoff 
points that were most informative in the 
regression model. Hosmer-Lemeshow 
Test was conducted for post-estimation 
of the model; a p-value> 0.5 supports 
goodness of fit.  
The Cohen k was calculated to evaluate 
the level of agreement between 3D-US 
and OH. 0.41 to 0.60 was considered 
moderate, 0.61 to 0.80 was substantial, 
and 0.81 to 1.00 was described as 
perfect. Two-tailed McNemar test was 
conducted to compare proportions 
within the same cohort. Diagnostic 
accuracy of imaging modalities was 
expressed in terms of sensitivity, 
specificity, positive, and negative 
predictive values (PPV, NPV).  
Results 
One hundred and twenty women met 
enrollment criteria and were recruited in 
this study. Their median (IQR) age was 
30 (23.8 – 36) years, with 52.5% (N= 
63) in their thirties and 25.8% (N= 31) in 
the late twenties. The median (IQR) 
duration of infertility was 6 (4 – 9.8) 
years. One-third of them reported prior 
IVF trials (40, 33.33%) with a mean (SD) 
number of trials of 1.68 ± 0.73. The 
indications for IVF treatment were a 
Proceedings in Obstetrics and Gynecology, 2020;10(1):5 
Role of 3D-US and OH in the detection of endometrial lesions. 5 
 
tubo-peritoneal factor (33.3%), 
anovulatory (28.3%), unexplained 
(16.7%), male infertility (15.8%) and 
combined factors (5.8%). The 
demographic and clinical characteristics 
of the study cohort are shown in Table 
1. 
 
Table1: Characteristics of women with and without cavitary lesions 
 
Patient characteristics Overall 
(n=120) 
Women without CLs 
(n=86) 
Women with CLs 
(n=34) 
P-value 
Female age, years 
Median (IQR) 
 
30 (23.8 - 36) 
 
29 (23 - 33.4) 
 
31.5 (27.4 - 37) 
 
0.009 
 
Infertility duration, years 
Median (IQR) 
 
 
6 (4 - 9.8) 
 
 
5.5 (3 - 8) 
 
 
 
6 (4 - 11) 
 
 
 
0.11 
 
BMI, kg/m2  
Median (IQR) 
 
25 (23 - 28) 
 
25 (23 - 28) 
 
24 (22.8 – 27.3) 
 
0.35 
 
Etiology of infertility (n, %) 
Male factor 
Ovulatory Dysfunction 
Tubo-peritoneal 
Unexplained 
Combined male and female 
 
 
19 (15.8%) 
34 (28.3%) 
40 (33.3%) 
20 (16.7%) 
7 (5.8%) 
 
 
 
13 (15.1%) 
25 (29.1%) 
26(30.2%) 
16 (18.6%) 
6 (7.0%) 
 
 
6 (17.6%) 
9 (26.5%) 
14(41.2%) 
4 (11.8%) 
1 (2.9%) 
 
 
0.66 
Menstrual pattern (n, %) 
Normal 
Oligomenorrhea 
Hypomenorrhea 
Heavy menstrual bleeding 
Irregular menstrual periods 
 
87 (72.5%) 
19 (15.8%) 
1 (0.8%) 
6 (5%) 
7 (5.8%) 
 
65 (75.6%) 
17 (19.8%) 
0 ( 0) 
2 (2.3%) 
1 (1.2%) 
 
22 (64.7%) 
2 (5.9%) 
1 (2.9%) 
4 (11.8%) 
6 (17.6%) 
 
0.26 
0.06 
N/A 
0.09 
0.002 
Prior IVF cycle(n, %) 40 (33.3%) 26 (30.2%) 14 (41.2%) 0.29 
Prior Endometrial procedure(n, 
%) 
11 (9.2%) 3 (3.5%) 8 (23.6%) 0.002 
CLs, endometrial cavitary lesions; BMI, body mass index; P value < 0.05 is considered significant 
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Figure 1: STARD (Standards for the Reporting of Diagnostic Accuracy Studies) 
flow diagram showing cavitary lesions diagnosed during uterine cavity 
assessment using three-dimensional transvaginal ultrasound (index method) and 
office hysteroscopy (reference method). 
Proceedings in Obstetrics and Gynecology, 2020;10(1):5 
 
Role of 3D-US and OH in the detection of endometrial lesions. 7 
 
During OH, no participants asked to 
stop the procedure, and no 
complications were reported. At the 
hysteroscopic examination, 34 women 
(28.3%) had CLs (Figure 1). More 
abnormalities were reported among 
women with prior IVF failure compared 
to those scheduled for their first trial 
(14/40; 35% versus 20/80; 25%, 
respectively). However, this difference 
was not statistically significant (P=0.25). 
These abnormalities included polyps 
(16, 47.1%), submucous myomas (8, 
23.5%), intrauterine adhesions (3, 
8.8%), uterine septa (3, 8.8%) and 
arcuate uterus (4, 11.8%). 
 
 
 
Figure 2: 2D- and 3D-US images of sub-mucosal myoma. 
 
Of the CLs, 30 were diagnosed by 3D-
US and 21 by 2D-US. Sensitivity, 
specificity, PPV, NPV and overall 
accuracy for 2D-US were 61.8%, 93%, 
77.8%, 86% and 84.2% respectively. 
2D-US showed perfect accuracy for 
SMM (Figure 2). 2D-US misdiagnosed 
13 cases as normal uterine cavity; 
however, most of the missed lesions are 
minimal. Anatomical description of the 
2D-misdiagnosed cases and their 
clinical presentations are shown in 
Table 2.  
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Table 2: Correlating anatomy with clinical presentations of the lesions missed by 
2D-US evaluation 
The  lesion  Anatomical description  Clinical presentations 
Polyps (n=5) Median (IQR), cm: 1.1 ( 0.7 – 1.3) 
Mean ± SD, cm: 1.02 ± 0.28 
 
0.8 cm low corporeal posterior polyp, oblong in shape. 
 
1.1 cm utero-tubal polyp thin fusiform in shape. 
 
 
0.6 cm utero-tubal polyp, oval in shape. 
 
 
1.2 cm utero-tubal polyp, thin fusiform in shape 
 
 
1.4 cm  high corporeal , lateral wall polyp, rounded in 
shape 
 
 
 
Asymptomatic 
 
 
History of prior 
polypectomy 
 
Asymptomatic 
 
 
Irregular menstrual 
periods(metrorrhagia) 
 
Irregular menstrual 
periods(metrorrhagia) 
IUA (n=2) Mid-corporeal, Moderate IUA. 
 
 
Low corporeal, Mild IUA appeared as filmy bands that 
started to be torn by the flow of the fluid during Office 
Hysteroscopy. 
Hypomenorrhea, 
History of prior 
myomectomy 
 
Asymptomatic 
Uterine Septum 
(n=2) 
2 residual septa 
1.6 cm residual septal length with a width of  2.1 cm 
1.5 cm residual septal length with a width of 2.2 cm. 
 
History of prior 
metroplasty 
Arcuate uterus 
(n=4) 
4 cases of concave fundal depression Asymptomatic 
Total missed 
lesions (n=13) 
  
2D-US; two-dimensional ultrasound, IUA; intrauterine adhesions 
 
The overall accuracy of 3D-US was 
94.2%, and the results of the coronal 
view examination of the uterine cavity by 
3D-US displays agreed with OH in 113 
subjects: 83 with a normal uterine cavity 
and 30 with CLs. The overall agreement 
between these two methods was near-
perfect (κ = 0.86, 95% CI = 0.75-0.96) 
(Table 3). 
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Table 3: Diagnostic accuracy parameters of 3D-US in the diagnosis of cavitary 
lesions and level of agreement with OH 
CL Sensitivity Specificity PPV NPV AUC κ value     95% CI 
SMM 100 100 100 100 100 1.0         1.0-1.0 
Polyps 81.3 99 92.9 97.2 96.7 0.85       0.70-0.99 
IUA 66.7 98.3 50 99.1 97.5 0.56         0.11-1.0 
Uterine Septum 100 100 100 100 100 1.0          1.0-1.0 
Arcuate uterus 100 100 100 100 100 1.0          1.0-1.0 
All 88.2 96.5 90.9 95.4 94.2 0.86       0.75-0.96 
3D-US, three-dimensional transvaginal ultrasound; CL, cavitary lesions; OH, office hysteroscopy; SMM, 
submucous myoma; IUA, intrauterine adhesions; AUC, accuracy; PPV, positive predictive value; NPV, 
negative predictive value 
 
For SMM, uterine septa, and arcuate 
uteri, 3D-US yielded 100% diagnostic 
accuracy and perfect agreement with 
OH (κ =1.00, 95% CI = 1.00-1.00)(Table 
3). For uterine polyps (Figure 3), four 
cases were falsely diagnosed by 3D-US; 
three false negatives and one false 
positive. Nevertheless, 3D imaging 
exhibits a near-perfect agreement with 
OH (κ =0.85, 95% CI = 0.70-0.99) for 
diagnosis of polyps. The median (IQR) 
size of all polyps was 1.95 cm (1.6-
2.28). 3D-US detected thirteen polyps 
(81.25%); their median (IQR) size was 
2.1 cm (1.8-2.35). The three missed 
polyps were generally smaller in size 
(0.6, 0.8, and 1.1 cm) and were missed 
by 2D-US as well. 
 
Figure 3: Coronal plane of the uterus showing three cases of endometrial polyps. 
Three-dimensional US exhibits the 
lowest sensitivity and PPV in identifying 
intrauterine adhesions (IUA); moderate 
concordance with OH was reported 
(κ=0.56, 95% CI=0.11-1.0)(Table 3) 
(Figure 4). Based on the European 
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Society of Gynecological Endoscopy 
classification,22 OH reported two 
moderate and one mild IUA. The latter 
case was missed by both 2D- and 3D-
US.
. 
 
Figure 4:Three-dimensional multi-slice view of the coronal plane of the uterus 
showing a case of moderate intrauterine adhesion (The Arrow) 
Inter/Intra-observer Agreement 
In terms of inter-observer agreement, κ 
was 1.00 (95% CI= 1.00-1.00) for SMM, 
arcuate uterus and septate uterus; 0.83 
(95% CI= 0.86-0.99) for polyps and 0.65 
(95% CI= 0.29-1.00) for IUA. Kappa for 
intra-observer agreement was 1.00 
(95% CI= 1.00-1.00) for SMM, polyps, 
arcuate uterus and septate uterus and 
0.74 (95% CI= 0.39-1.00) for IUA. These 
results denote prefect inter/intra-
observer agreement for 3D MPV and 
MSV in the diagnosis of SMM, polyps, 
arcuate uterus, and septate uterus and 
substantial inter/intra-observer 
agreement in the diagnosis of IUA. 
Prediction of CLs 
A univariate regression model was 
conducted to identify potential predictors 
of CLs (Table 4). Female age 30 years 
or more, irregular menstrual periods 
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(metrorrhagia), heavy menstrual 
bleeding, and history of a prior 
endometrial procedure (hysteroscopic 
myomectomy, polypectomy, and 
metroplasty) were more common among 
women with CLs than women with 
normal uterine cavities. However, only 
irregular menstrual periods (aOR = 
24.96, 95% CI=2.71 – 230.04, P =0.005) 
and a previous procedure (aOR = 9.16, 
95% CI=2.13 – 39.3, P=0.002) were 
significant in multivariate analysis (Table 
4). 
Table 4: Univariate and Multivariate regression model for testing possible 
predictors of the cavitary lesions 
Predictor 
 
Unadjusted 
odds ratio 
CI P value Adjusted  
odds 
ratio* 
CI P value 
 
Female age ≥ 30 years  2.40 1.04 – 5.54 0.04    
 
Infertility duration 
 
1.09 
 
0.97 – 1.21 
 
0.14 
   
 
Body mass index 
 
0.93 
 
0.80 – 1.09 
 
0.34 
   
 
Heavy menstrual bleeding 
 
5.6 
 
0.98 – 32.16 
 
0.05 
   
 
Irregular menstrual periods 
 
18.21 
 
2.1 – 157.88 
 
0.008 
 
24.96 
 
2.71 – 230.04 
 
0.005 
 
Prior IVF cycle 
 
1.62 
 
0.71 – 3.68 
 
0.25 
   
 
Prior endometrial 
procedure 
 
8.51 
 
2.1 – 34.46 
 
0.003 
 
9.16 
 
2.13 – 39.3 
 
0.002 
 
* Multivariate analysis includes variables with P values < 0.2 in univariate analysis   
 
Based on our dataset, selective 
hysteroscopic evaluation of women, 
based on abnormal 2D-US and/or 
clinical predictors; irregular menstrual 
periods and prior endometrial 
procedure, would have an NPV of 92.8 
% and would miss only six cases (6/34; 
17.6 %). These six cases would include 
four arcuate uteri and two endometrial 
polyps (0.6 and 0.8 cm). This selective 
strategy would be comparable to the 
global screening of women using OH in 
diagnostic accuracy (McNemar P=0.61). 
 
Discussion 
Adequate visualization of the 
endometrial cavity is required before 
embarking on IVF treatment. OH has 
been popularly assigned for this 
purpose however; it is not universally 
required before IVF treatment. Two 
recent well-designed RCTs 
demonstrated no differences in remote 
clinical outcomes following OH 
application in women enrolled for first 
and subsequent IVF cycles.13,23 
However, data still lacks the prevalence 
of CLs in women for IVF therapy, their 
anatomical and clinical behavior, and 
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the fertility prospects of their uteri after 
surgical resection. Therefore, exploring 
alternatives to OH, which yield less 
financial burden and higher patient 
acceptability, is an area of research. 
In this study, we evaluated the uterine 
cavity of women scheduled for IVF using 
combined 3D MPV and MSV to warrant 
better diagnostic performance. The 3D-
US examination not only visualizes the 
uterine cavity abnormalities but also 
enables the clinician to examine the 
external contour and myometrial 
structure of the uterus. 
Our findings for 3D-US diagnostic 
accuracy concurred with those reported 
by Van den Bosch et al. when 
examining the uterine cavity 
categorizing the results in their analysis 
as a normal or abnormal cavity. They 
reported sensitivity, specificity, and 
accuracy of 96%, 91%, and 93%, 
respectively.24 Bocca et al. reported 
100% detection rates for congenital 
anomalies, fibroids, and IUA. while 3D-
US missed only one case of 38 polyps 
diagnosed in their cohort.25  
We found that the highest accuracy of 
3D-US was for diagnosing congenital 
anomalies and SMM. According to a 
meta-analysis reported by Saravelos et 
al., 3D-US is a definitive tool for 
diagnosing congenital anomalies.26 Our 
findings for SMM are also comparable to 
those reached by Salim et al.27 
Slightly higher accuracy parameters 
than ours were shown by studies adding 
saline infusion to the 3D scan. However, 
these reports did not include a 
description of the detected lesions. El-
Sherbiny et al. examined 120 women in 
reproductive age by 3D saline infusion 
sonography (3D-SIS). They reported 
sensitivity, specificity, PPV, NPV, and 
overall accuracy of 94.2%, 98.5%, 98%, 
95.7%, and 96.7% respectively.28 In 
another study which included 180 
infertile women with normal 2D-US and 
HSG, the accuracy parameters were; 
92%, 100%, 100%, 98%, 98.8% 
respectively.8  
Because of four false negatives, the 
overall agreement between 3D-US and 
OH was near-perfect. A substantial level 
of agreement (k=0.77; 95% confidence 
interval, 0.6–0.84) between 3D-SIS and 
OH was found in a study by Negm et al. 
when 146 women with recurrent 
implantation failure were assessed.29  
Based on our results, the diagnostic 
performance of either 2D-US or 3D-US 
decreased when assessing small polyps 
one cm or less. This may be due to the 
absence of enhanced imaging by saline 
infusion in our design. A recent study 
concluded a similar trend of 3D-US for 
such polyp size.30 Although evidence 
from basic science research supports 
that polyps may impair implantation,11,31 
clinical evidence argued that such small 
polyp size, not recognized by 3D-US, 
does not affect IVF outcome.32-34 
Analyzing the subgroup of 
asymptomatic IVF women in our cohort 
with normal 2D-US and with no clinical 
risk factors will show a similar 
prevalence (10%) of subtle, minimal 
lesions compared to what reported 
previously.3,13 In this subpopulation, 3D-
US added information only for the 
arcuate and septate uterus. Because 
the availability of 3D-US and familiarity 
with its use in IVF practice are not 
guaranteed, especially in low resource 
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settings, we evaluated an alternative 
strategy that may minimize the use of 
OH for the detection of CLs. This 
strategy depends on the use of 2D-US, 
being more popular and readily 
available, along with clinical predictors 
that could enhance the diagnostic 
accuracy of this strategy. 
In our study, both irregular menstrual 
periods (metrorrhagia) and prior 
endometrial traumatization were 
significant risk factors to have a CL. 
Abnormal anatomical finding, adhesions 
or residual septum have been described 
following hysteroscopic myomectomy 
and metroplasty, respectively.35-37 Even 
though, after complete removal of the 
septum, adhesions, or septal remnants 
may occur.38 Age was not recognized as 
a predictor in our cohort. Predictability of 
age for CLs in similar cohorts was 
controversial; El-mazny et al.7 and 
Feghali et al.39 found no association 
between a woman's age and the 
distribution of CLs. In contrast, Taskin et 
al. found that CLs were more prevalent 
in women aged 35 or more compared to 
the younger age group (45.4% vs. 
27.9%, P= .002).6  
Selective OH assessment discriminating 
women with abnormal 2D-US findings 
and/or significant clinical predictors 
would substantially decrease the cost 
per case detected to 37.4% of that cost 
if all women were screened with OH. 
This will help better allocate health 
resources in low resource and income 
settings. Moreover, most of the missed 
diagnoses by the selection would be 
arcuate uteri that have been reported 
not to affect implantation substantially.  
The use of 3D combined displays for 
visualization of the uterus in IVF women 
as an alternative to OH presents a point 
of strength in this study. Another point is 
addressing a new clinical/imaging 
strategy in terms of costs and diagnostic 
accuracy, especially in the absence of a 
clear approach to screen IVF women 
with normal 2D-US who are clinically at 
risk to have a CL. However, the small 
sample size is a key limitation of our 
study. Another limitation is the lack of 
histopathology as a reference standard 
to detect chronic endometritis, a subtle 
endometrial abnormality that has been 
linked recently to recurrent implantation 
failure.40  
Conclusions 
In conclusion, 3D-US provides an 
accurate, non-invasive alternative to OH 
for large cavitary lesions. It has the 
advantage of cost and patient 
convenience. This is of particular benefit 
in women with remote HSG as new 
lesions could develop over time.41 
Alternatively, a selective strategy that 
considers 2D-US in combination with 
clinical predictors may present an option 
to reduce the costs of the pre-IVF work 
up, particularly in low resource areas. 
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